Medical Equipment

Cardiovascular Implants Market Performance and Future Outlook at 6.4% CAGR Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cardiovascular implants market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Cardiovascular Implants Industry By 2029?

The cardiovascular implants market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $26.8 billion in 2024 to $28.68 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.0%. This past growth can be ascribed to an aging population alongside cardiovascular risk, lifestyle-associated cardiovascular risk factors, enhancements in diagnostic technologies, increasing awareness and screening initiatives, and governmental programs promoting cardiovascular health.

The cardiovascular implants market size is anticipated to experience robust expansion over the coming years. Its value is projected to reach $36.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is primarily driven by personalized medicine approaches, a focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, and patient-centric cardiovascular care. Furthermore, significant trends expected within this forecast period encompass advancements in drug-eluting stents, the emergence of next-generation heart valves, increasing integration of artificial intelligence (ai), a focus on minimally invasive implantation techniques, personalized and patient-specific implants, and the development of leadless pacemakers.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp

What Major Drivers Are Impacting The Cardiovascular Implants Market?

The increasing incidence of heart disorders is projected to stimulate the expansion of the cardiovascular implants market moving forward. Heart disorders encompass a variety of medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The widespread occurrence of heart conditions, such as coronary artery disease and heart failure, fuels the demand for cardiovascular implants like stents and pacemakers, which are used to treat these ailments. These implants provide support for the heart and circulation in patients experiencing heart failure, aid in maintaining a regular heart rhythm, and track cardiac activity. As an illustration, in September 2024, a report from the British Heart Foundation (BHF), a UK-based charity funding research and promoting awareness of heart and circulatory diseases, revealed that roughly 7.6 million individuals in the UK are afflicted by heart and circulatory diseases. By 2030, the population in the UK living with heart and circulatory diseases could see an increase of 1 million, and by 2040, this number might escalate by 2 million, beyond the current figures. Therefore, the growing prevalence of heart disorders is serving as a primary driver for the cardiovascular implants market’s growth.

Which Segment Categories Are Driving Maximum Growth In The Cardiovascular Implants Market?

The cardiovascular implantsmarket covered in this report is segmented –

1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent

2) By Material: Metals and Alloys, Polymers, Biological Materials

3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications

4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents

2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD

3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves

4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker

5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)

6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

Which Long-Term Trends Will Play A Crucial Role In The Cardiovascular Implants Market?

Leading companies within the cardiovascular implants market are increasingly focusing on incorporating advanced technology, including artificial intelligence (AI), to optimize their profits and improve patient care and treatment accuracy. The advancement of cardiac monitoring technology involves the continuous tracking and recording of a patient’s heart activity to accurately diagnose and manage various heart conditions. For example, in June 2023, BIOTRONIK SE & Co. KG, a Germany-based medical technology company, announced the first worldwide implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV represents a state-of-the-art ICM that merges BIOTRONIK’s SmartECG technology with artificial intelligence, effectively reducing false-positive detections by 86% while preserving 98% of actual cardiac events. Beyond its sophisticated AI, the BIOMONITOR IV provides multiple advantages for both patients and medical practitioners, including an extended battery life and wireless connectivity, which enable smooth data transmission and remote monitoring, thereby reducing the necessity for frequent in-person clinic visits.

Who Are The Dominant Players In The Cardiovascular Implants Market Today?

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Which Region Is At The Forefront Of Innovation In The Cardiovascular Implants Market?

North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13399&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Implants Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795